Status:
COMPLETED
Treatment of Non-Gestational Acute Uterine Bleeding: A Randomized Trial
Lead Sponsor:
Kaiser Permanente
Conditions:
Uterine Hemorrhage
Menorrhagia
Eligibility:
FEMALE
18-65 years
Phase:
NA
Brief Summary
To determine the relative efficacy of multidose medroxyprogesterone acetate (MPA, Provera) and a multidose, monophasic combination oral contraceptive in the treatment of hemodynamically stable women w...
Detailed Description
Acute uterine bleeding, unrelated to pregnancy, is a relatively common problem that causes many reproductive-aged women to requite emergent medical and/or surgical intervention. Although the tradition...
Eligibility Criteria
Inclusion
- Non-pregnant Hemodynamically stable Reproductive-aged women \>18 years Present with acute uterine bleeding
Exclusion
- Pregnant Non-hemodynamically stable \<18 years
Key Trial Info
Start Date :
April 1 2003
Trial Type :
INTERVENTIONAL
End Date :
June 1 2005
Estimated Enrollment :
240 Patients enrolled
Trial Details
Trial ID
NCT00350480
Start Date
April 1 2003
End Date
June 1 2005
Last Update
March 11 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kaiser Permanente Sunset
Los Angeles, California, United States, 90027